Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

NCT04006041 is registered in ClinicalTrials.gov with Jianhua Fu as lead sponsor.

NCT NCT04006041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04006041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
Lead sponsor
Jianhua Fu
Phase
Phase 2
Overall status
Unknown status
Start date
June 25, 2019
Completion date
December 31, 2020
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal squamous cell carcinoma by ajcc v8 stage, resectable esophageal cancer